Abstract:A 34-year-old Chinese woman was referred to our hospital at 24 weeks of gestation for persistent hypokalaemia and new onset of hypertension. Prior to pregnancy, she had a three-year history of recurrent episodes of muscle weakness and found to have low potassium levels (the lowest level was 1.8 mmol/L, normal 3.5–5.3 mmol/L). During the clinical visits, her blood pressure was normal, consistently 110–120/70–80 mmHg, until the twenty-third week of pregnancy, when it was found to be 160/100 mmHg. During her hospitalisation, blood pressure remained elevated despite treatment, with a peak level of 210/130 mmHg. Diagnostic evaluation included potassium levels, which remained low at 2.94–3.65 mmol/L despite supplementation; urinary protein was 1.98 g/24 h; urinary potassium excretion was 48 mmol/24 h, suggesting renal loss of potassium. The plasma renin activity (PRA) was 0.76 ng/mL/h (normal 0.2–1.9 ng/mL/h in non-pregnancy); plasma aldosterone concentration (PAC) was 830 pg/mL (normal 21–136 pg/mL in non-pregnancy), with a PAC-to-PRA ratio of 109. Urine catecholamines, plasma corticotrophin, cortisol and calcium concentrations were almost normal. Ultrasound scan identified a parenchymatous mass in the left adrenal gland. Primary aldosteronism was suspected, but surgery during pregnancy was not considered due to lack of expertise in this setting, though laparoscopic adrenalectomy during pregnancy might be a possible choice for treatment. Conservative treatment was adopted to prolong the pregnancy as much as possible, including nitroglycerin, nifedipine, labetabol, furosemide, magnesium sulfate, potassium supplement and other supportive therapies. Spironolactone was not adopted considering its uncertain effect to the fetus, although there was a report of it being used safely at high dose in a mother with Batter’s syndrome for two pregnancies without evidence of harm to male infants. Emergency caesarean section was performed at the twenty-fifth week of gestation because of HELLP syndrome (type III), uncontrolled hypertension and mild placental abruption. Her blood pressure decreased after delivery but not to normal. Abdominal computed tomography six months later confirmed a tumour in the left adrenal gland (Fig. 1). Laparoscopic adrenalectomy was then performed and pathological analysis confirmed a cortical adenoma of the left adrenal gland. After surgery, her serum potassium level and blood pressure gradually returned to normal. PRA, PAC and PAC-to-PRA ratio all returned to normal after three months. On follow up, serum potassium levels and blood pressure have remained normal without medication. This patient was not hypertensive in early pregnancy, most probably due to the physiological vasodilation that occurs in pregnancy. Hypertension due to Conn’s may not become apparent until midto late pregnancy (as occurred for this patient) or until post-partum. Persistent hypokalaemia, with increased potassium loss in urine, as occurred in this case, Correspondence: Professor Hong Li, 3 East Qingchun Road, Sir Run Run Shaw Hospital, Hangzhou 310016, China. Email: lihongheyi@126.com

Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration

Effect of Oral Contraception on Screening Tests for Primary Aldosteronism: A 10-Year Longitudinal Study

EFFECTS OF MINERALOCORTICOID RECEPTOR ANTAGONISTS ON ALDOSTERONE TO RENIN RATIO IN PATIENTS WITH PRIMARY ALDOSTERONISM

[Aldosterone-to-renin Ratio Threshold for Screening Primary Aldosteronism in Chinese Hypertensive Patients].

Comparing ARR Versus Suppressed PRA as Screening Tests for Primary Aldosteronism

Clinical Significance of Aldosterone to Renin Ratio in Screening Primary Aldosteronism

The Association Between Egfr and the Aldosterone-to-Renin Ratio and Its Effect on Screening for Primary Aldosteronism.

Diagnostic Accuracy of Aldosterone and Renin Measurement by Chemiluminescence for Screening of Patients with Primary Aldosteronism

Steroidomics-Based Screening for Primary Aldosteronism: Impact of antihypertensive Drugs

Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups

Case Series: Primary Aldosteronism Diagnosed Despite Normal Screening Investigations: A Report of Three Cases

Performance of aldosterone-to-renin ratio before washout of antihypertensive drugs in screening of primary aldosteronism

Variable effect of the post-partum menstrual cycle on aldosterone and renin in women with recent preeclampsia

Prevalence of High Aldosterone-Renin Ratio in Patients With Hypertension in Basrah

Primary Aldosteronism and Pregnancy: A Case Report

Clinical significance of LC-MS/MS aldosterone in screening for primary aldosteronism

8562 Mineralocorticoid Receptor Antagonist Do Not Prevent Primary Aldosteronism Subtyping by Adrenal Vein Sampling

Effect of Sodium Glucose Co-Transporter-2 Inhibition on the Aldosterone/Renin Ratio in Type 2 Diabetes Mellitus

Analysis of the influencing factors for screening primary aldosteronism

Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trial

Efficacy of screening for primary aldosteronism by adrenocortical scintigraphy without discontinuing antihypertensive medication